Lung Diseases Clinical Trial
Official title:
Diagnostic Value of Chest Ultrasound in Detecting Causes of Radiological Opacities in Comparison to CT Scan Among Children at Assiut University Children Hospital
To evaluate the accuracy of chest ultrasound for diagnosis of different lung lesions in comparison to the gold standard among children.
Lung disease are the most common condition in pediatrics and also the primary cause of death
among children less than 5 years old(Chen Shui-Wen et al.,2015).
Chest X ray consider as the first line to evalute the chest disease (Kim O et al. ,2000), in
identified the pulmonary opacities (Ozkaya A et al., 2018),but there is limitation in the
interpretation of the location and nature of an area of increase opacity on chest radiographs
particularly in young infants with varied configuration of thymus and differentiation between
pulmonary , pleural and mediastinal lesions is not always easy(Barillari A et al .,2011),so
the thoracic computed tomography is recommended as diagnostic gold standard to follow up
pediatric chest X ray opacities and masses(Lameh A et al. ,2019),but not consider as first
line of radiological evaluation because each chest computed tomography gives to patient an
effective dose of eight msv equivalent to four hundred chest X ray (Prithviraj D.,2014), also
high cost ,and longe waiting times for imaging (Lameh A et al .,2019).
Chest sonography consider as first line investigation in evaluation of diaphragmatic ,pleural
and chest wall lesions due to lack of superficial adipose tissue in pediatric patients (Goh
Y, et al. ,2016),but undervalued for lungs lesion for many years ,because the ribs ,sternum
and aerated lungs had been considered obstacles to ultrasound waves (Dietrich C, et al.,
2015). However improvements in technology have lead to production of higher-resolution
transducers and techniques such as tissue harmonic imaging, which lead to improved spatial
resolution and deeper tissue penetration of ultrasound waves (Lameh A et al. ,2019),also the
pathological processes as inflammations ,trauma or neoplastic within the chest wall ,pleural,
and lungs result in profound changes in tissue composition and improved acoustic transmission
and allow for adequate lungs sonographic evaluation(Dietrich C, et al., 2015).
Chest sonography serves as a powerful complementary diagnostic tool with advantage of easy
availability ,rapid ,radiation free (Dietrich C, et al., 2015), repeatable and inexpensive
methods, determining the high diagnostic accuracy in detecting pediatric chest lesions (Lameh
A et al .,2019).
Causes of pediatric chest X ray opacity:
Radio-opacities are more common and significant compared to increased radiolucency , can be
caused by many different pathologies and present with different patterns (Gelaw S.,2015), as:
Consolidation:
Caused by replacement of the air in distal airways and the alveoli by fluid or soft tissues.
Radiological, this is seen as opacity of any size and mostly homogenous, it has no volume
loss, has the tendency to coalescence, has ill-defined margins, non-segmental distribution,
irregular shape, air bronchogram (Gelaw S.,2015).
By ultrasound its similar in echogenicity and echotexture to liver and spleen. Bronchograms
present within the solid appearing area of echogenicity as multiple bright dot like , and
branching linear structures represent air in bronchi and scattered residual air in
alveoli(Barillari A et al. ,2011).
Differentiate from atelectasia by presence of dynamic air bronchogram (Barillari A et al
.,2011).
Collapse (atelectasis):
This may affect the whole hemi-lung or sub-division of the lungs, such as the lobes ,
segments or subsegments of the lung. Radiological, it causes opacity and signs of volume
loss(Gelaw S.,2015).
It is important to to differentiate focal areas of cosolidation from those of collapse ,since
collapse may be associated with a foreign body inhalation or other extrinisic obstruction
(Arthur R.,2003) . By chest ultrasound atelectasis similar in echogenicity and echotexture to
liver and the air broncograms appear crowded and parallel (Barillari A et al.,2011).
Interstitial opacities:
This is the common presentation of chronic diffuse interstitial lung diseases (Gelaw
S.,2015).
Lung ultrasound is an emerging tool in diagnosis of interstitial lung diseases by evaluation
number of B lines ,pleural irregularities and nodules or consolidation (Falcetta et al.,
2018).
Pleural/chest wall opacities:
Pleural opacities, such as pleural mass lesion, pleural thickening or calcification or mass
arising from soft tissue or bony chest wall (Gelaw S., 2015) , in the pleural effusion is
challenging to differentiate between the pleural effusion and consolidation by the X ray
especially in hemithorax (Prina E., 2014).ultrasound provides detailed information about the
nature of pleural fluid and allows one to determine whether a fluid collection is amenable to
aspiration (Kim O et al., 2000).
Nodular opacities or mass:
These are rounded increased opacities that can be caused by different pathologies.
Radiological , these can be seen on any location, with sizes ranging from pinpoint to mass
(it is called mass if >3 cm), solitary or multiple (such as miliary nodules, if multiple
small nodules ≈2 mm in diameter), can have different shapes; and margins can be smooth,
umbilicated or lobulated. The outline can be sharp, ill-defined or speculated (Gelaw
S.,2015).
Ring opacities:
These are annular opacities with central radiolucency usually due to cavitations of
pre-existing lesion, but also can be caused by bullae, benign air cyst, loculated
pneumothorax or fibrocystic changes (Gelaw S.,2015).
Linear opacities:
These are thin or thick (band shadow, if 5 mm or more) linear shadows. The most common
abnormal linear opacity is a scar. Post-primary tuberculosis commonly heals with fibrosis
presenting with irregular linear opacities with or without volume loss (Gelaw S.,2015).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 |